1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1610
  5. Art Unit 1618
  6. Examiner Westerberg

Examiner Westerberg Nissa M

1618-WESTERBERG-NISSA-M

Employment Information

Art Unit:1618 — Drug, bio-affecting and body treating compositions
Group:1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents
Classes: 424 — Drug, bio-affecting and body treating compositions
514 — Drug, bio-affecting and body treating compositions
604 — Surgery
600 — Surgery
435 — Chemistry: molecular biology and microbiology
Phone:(571) 270-3532
Email:nissa.westerberg@uspto.gov
Location:VA 22314
Title:Pat Examnr Org Chem
Service:19 years
Grade:GS-14

Grant Rate and Difficulty Ranking

93
3-Year Grant rate: 20% over 275 cases
Difficulty: Extremely Hard
Difficulty Percentile: 93rd

With Examiner Westerberg, you have a 20% chance of getting an issued patent by 3 years after the first office action. Examiner Westerberg is an extremely hard examiner and in the 93rd percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Westerberg, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1618

Examiner Westerberg's grant rate is lower than that of Art Unit 1618 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Westerberg 2.5
Art Unit 1618 2.0

Interview Benefit

Grant Rate without Interview

Examiner Westerberg has granted 29 of 179 cases without any applicant-requested interviews for a grant rate of 16%.

Grant Rate with Interview

Examiner Westerberg has granted 25 of 96 cases with at least one applicant-requested interview for a grant rate of 26%.

Interview Benefit

With Examiner Westerberg, conducting an interview increases your chance of getting a patent granted by 62%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18624853 Antimicrobial Composition Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
18099188 Contrast Agent And Precursor And Manufacturing Method Thereof Abandoned View
18097486 High Penetration Prodrug Compositions Of Prostaglandins And Related Compounds Abandoned View
17143148 Antimicrobial Compositions Abandoned View
15768141 Methods And Compositions Related To Magneto-Elasto-Electroporation (Meep) Abandoned View
16710695 Eye-Injectable Polymeric Nanoparticles And Method Of Use Therefor Abandoned View
17864077 Ultra-Deformable Liposomes For Drug Delivery Abandoned View
16760527 Drug Delivery Systems And Methods Comprising Polysialic Acid And/or Other Polymers Abandoned View
18558015 Compositions And Methods For Targeting Lipid Nanoparticle Therapeutics To Stem Cells Abandoned View
18621526 Supramolecular Ionizable Lipid Molecules With Heteroatomic Tuning For Nucleic Acid Delivery Patented View
16770543 Photodynamically Active Organosilica Nanoparticles And Medical Uses Thereof Abandoned View
17423108 Microcapsule Composition Using Alginate Gel, And Method For Producing Same Abandoned View
17511864 Biopsy Device Marker And Related Methods Abandoned View
17265988 Monoamine Oxidase B Imaging Probe Patented View
17076600 Precision Chemical Ablation And Treatment Of Tissues Abandoned View
18022192 [18f]-Labeled Imidazopyridine Derivatives As Pet Radiotracer Patented View
17520972 Water-Soluble Compound For Detection Of Beta-Amyloid Patented View
17287748 Dendritic Polymers Complexed With Immune Checkpoint Inhibitors For Enhanced Cancer Immunotherapy Abandoned View
17348258 Functionalized Superabsorbent Material For Use In Lesion Phantom Patented View
17791824 Sustained Immunotherapy Abandoned View
17597515 Compounds Useful For Inhibiting Bfl1 And Their Use In Therapy Patented View
18812148 Rapid Forming Artificial Blood Vessel And Preparation Method Abandoned View
18600459 Chemical Composition For Enteric Drug Delivery Abandoned View
17905623 Colloidal Carrier Systems For Transfer Of Agents To A Desired Site Of Action Abandoned View
17142698 Polymeric Prodrugs With A Self-Immolative Linker Abandoned View
16907055 Polymeric Bile Acid Ester Nanoparticles To Induce Tolerance Abandoned View
18462701 Fibrin Particles And Methods Of Making The Same Patented View
17376099 Method Of Administering Local Anesthetic Solution For Dental And/or Contrast Media Use Abandoned View
17753893 Methods For Triggering M1 Macrophage Polarization Abandoned View
17416284 Conjugates Abandoned View
17303878 Encapsulation And High Encapsulation Efficiency Of Phosphorylated Active Agents In Nanoparticles Abandoned View
18087087 Peptide-Nanoparticle Conjugates Abandoned View
16448444 Auto-Oxidizing Aerosol Foam Hair Color Abandoned View
16331378 Method For Treating Keratinous Materials Using Aminated And Oxidised Polysaccharide Abandoned View
16184379 Tiny Nanoparticles For Magnetic Resonance Imaging Applications Abandoned View
17131956 Color Changing Silk Patch For Visible Ros Detection Abandoned View
17298436 Dendrimer For Therapy And Imaging Abandoned View
18351952 Coloring Ultraviolet Protective Agent Abandoned View
17598558 Method Of Preparing Nanoplateform-Based Diagnostic Agent For Selectively Staining Of Inflammatory Abnormal Tissue Or Tumor Tissue Abandoned View
17290337 Methods For Synthesis Of Radionuclide Complex Abandoned View
16906695 Polymeric Bile Acid Nanoparticles As Anti-Inflammatory Agents Abandoned View
18445165 Formulated And/or Co-Formulated Liposome Compositions Containing Toll-Like Receptor("tlr") Agonist Prodrugs Useful In The Treatment Of Cancer And Methods Thereof Patented View
17421607 Manganese Ferrite Nanoparticles For Use As Mri Contrast Agents And Magnetohypothermia Agents Abandoned View
17416592 Sleep Modulation Agent Abandoned View
18402112 Bamboo Charcoal Powder-Based False Eyelashes And Preparation Process Thereof Patented View
17560820 Immunostimulatory Lipoplex, Pharmaceutical Composition Including Immunostimulatory Lipoplex, And Uses Thereof Abandoned View
17290906 Alginic Acid-Based Injectable Hydrogel System Abandoned View
17153123 Method Of Preparing A Cosmetic Composition Abandoned View
16076243 Dendrimer-Bioadhesive Polymer Hydrogel Nanoglue And Use Thereof Abandoned View
16772113 Amphiphilic Block Copolymers, Micelles, And Methods For Treating Or Preventing Heart Failure Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.